SE9101838D0 - Novel peptides and their use - Google Patents

Novel peptides and their use

Info

Publication number
SE9101838D0
SE9101838D0 SE9101838A SE9101838A SE9101838D0 SE 9101838 D0 SE9101838 D0 SE 9101838D0 SE 9101838 A SE9101838 A SE 9101838A SE 9101838 A SE9101838 A SE 9101838A SE 9101838 D0 SE9101838 D0 SE 9101838D0
Authority
SE
Sweden
Prior art keywords
pro
arg
phe
pct
polypeptides
Prior art date
Application number
SE9101838A
Other languages
English (en)
Other versions
SE468516B (sv
SE9101838L (sv
Inventor
J-Y Lee
Original Assignee
Kabigen Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabigen Ab filed Critical Kabigen Ab
Priority to SE9101838A priority Critical patent/SE468516B/sv
Publication of SE9101838D0 publication Critical patent/SE9101838D0/sv
Priority to DK92912631T priority patent/DK0589995T3/da
Priority to ES92912631T priority patent/ES2131528T3/es
Priority to JP50081893A priority patent/JP3532917B2/ja
Priority to US08/162,052 priority patent/US5489575A/en
Priority to AT92912631T priority patent/ATE178072T1/de
Priority to PCT/SE1992/000394 priority patent/WO1992022578A1/en
Priority to DE69228749T priority patent/DE69228749T2/de
Priority to EP92912631A priority patent/EP0589995B1/en
Priority to AU20220/92A priority patent/AU667472B2/en
Priority to CA002111340A priority patent/CA2111340C/en
Publication of SE9101838L publication Critical patent/SE9101838L/sv
Publication of SE468516B publication Critical patent/SE468516B/sv
Priority to GR990400977T priority patent/GR3029887T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
SE9101838A 1991-06-14 1991-06-14 Nya polypeptider vilka kan utvinnas fraan tunntarmen och deras anvaendning SE468516B (sv)

Priority Applications (12)

Application Number Priority Date Filing Date Title
SE9101838A SE468516B (sv) 1991-06-14 1991-06-14 Nya polypeptider vilka kan utvinnas fraan tunntarmen och deras anvaendning
CA002111340A CA2111340C (en) 1991-06-14 1992-06-10 Novel polypeptides and their use
PCT/SE1992/000394 WO1992022578A1 (en) 1991-06-14 1992-06-10 Novel polypeptides and their use
ES92912631T ES2131528T3 (es) 1991-06-14 1992-06-10 Nuevos polipeptidos y su uso.
JP50081893A JP3532917B2 (ja) 1991-06-14 1992-06-10 新規なポリペプチドおよびその使用
US08/162,052 US5489575A (en) 1991-06-14 1992-06-10 Polypeptides and their use
AT92912631T ATE178072T1 (de) 1991-06-14 1992-06-10 Neuartige polypeptide und ihre verwendung
DK92912631T DK0589995T3 (da) 1991-06-14 1992-06-10 Hidtil ukendte polypeptider og deres anvendelse
DE69228749T DE69228749T2 (de) 1991-06-14 1992-06-10 Neuartige polypeptide und ihre verwendung
EP92912631A EP0589995B1 (en) 1991-06-14 1992-06-10 Novel polypeptides and their use
AU20220/92A AU667472B2 (en) 1991-06-14 1992-06-10 Novel polypeptides and their use
GR990400977T GR3029887T3 (en) 1991-06-14 1999-04-05 Method of preparing a radioactive rhenium complex solution.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9101838A SE468516B (sv) 1991-06-14 1991-06-14 Nya polypeptider vilka kan utvinnas fraan tunntarmen och deras anvaendning

Publications (3)

Publication Number Publication Date
SE9101838D0 true SE9101838D0 (sv) 1991-06-14
SE9101838L SE9101838L (sv) 1992-12-15
SE468516B SE468516B (sv) 1993-02-01

Family

ID=20383046

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9101838A SE468516B (sv) 1991-06-14 1991-06-14 Nya polypeptider vilka kan utvinnas fraan tunntarmen och deras anvaendning

Country Status (12)

Country Link
US (1) US5489575A (sv)
EP (1) EP0589995B1 (sv)
JP (1) JP3532917B2 (sv)
AT (1) ATE178072T1 (sv)
AU (1) AU667472B2 (sv)
CA (1) CA2111340C (sv)
DE (1) DE69228749T2 (sv)
DK (1) DK0589995T3 (sv)
ES (1) ES2131528T3 (sv)
GR (1) GR3029887T3 (sv)
SE (1) SE468516B (sv)
WO (1) WO1992022578A1 (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0665239A1 (en) * 1994-01-26 1995-08-02 Consiglio Nazionale Delle Ricerche Peptide derivatives of bactenecin endowed with antibacterial activity
US5654273A (en) * 1994-09-22 1997-08-05 Children's Medical Center Corporation Synducin mediated modulation of tissue repair
US6133233A (en) * 1997-02-18 2000-10-17 Kansas State University Research Foundation Peptide modulation of reperfusion injury
EP1019070A4 (en) * 1997-04-23 2001-05-16 Univ Michigan BRADYKININ ANALOGS AS SELECTIVE INHIBITORS OF CELL ACTIVATION
US6982249B1 (en) 1997-04-23 2006-01-03 The Regents Of The University Of Michigan Bradykinin analogs as selective inhibitors of cell activation
US7147633B2 (en) * 1999-06-02 2006-12-12 Boston Scientific Scimed, Inc. Method and apparatus for treatment of atrial fibrillation
EP1187652B1 (en) * 1999-06-02 2006-10-11 Boston Scientific Limited Devices for delivering a drug
US6676679B1 (en) 1999-11-05 2004-01-13 Boston Scientific Corporation Method and apparatus for recurrent demand injury in stimulating angiogenesis
JP2003512884A (ja) * 1999-11-05 2003-04-08 マイクロハート， インコーポレイテッド 新脈管形成の刺激における需要部損傷のための方法および装置
US6748258B1 (en) 1999-11-05 2004-06-08 Scimed Life Systems, Inc. Method and devices for heart treatment
AU2599001A (en) * 1999-12-29 2001-07-09 Beth Israel Deaconess Medical Center Method for pr-39 peptide mediated selective inhibition of ikappabalpha degradation
EP1267729A2 (en) 2000-03-23 2003-01-02 SciMed Life Systems, Inc. Pressure sensor for therapeutic delivery device and method
US7214223B2 (en) * 2000-03-24 2007-05-08 Boston Scientific Scimed, Inc. Photoatherolytic catheter apparatus and method
WO2002000278A2 (en) 2000-06-26 2002-01-03 Microheart, Inc. Method and apparatus for treating ischemic tissue
US20020065397A1 (en) 2000-10-12 2002-05-30 Joseph Roberts Protecting therapeutic compositions from host-mediated inactivation
US7250398B2 (en) 2003-09-12 2007-07-31 Novozymes A/S Synthetic antimicrobial polypeptides
BRPI0414253A (pt) * 2003-09-12 2006-11-21 Novozymes As polipeptìdeo, polinucleotìdeo, construção de ácido nucléico, vetor de expressão recombinante, célula hospedeira recombinante, métodos para produzir um polipeptìdeo, e para matar ou inibir o crescimento de células microbianas, composição, uso de um polipeptìdeo, planta transgênica, parte de planta ou célula vegetal, e, aditivo de ração animal
JP2007314432A (ja) * 2006-05-23 2007-12-06 Japan Science & Technology Agency 新規抗菌性ペプチド及び該抗菌性ペプチドを有効成分とする無血清培地

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856588T2 (de) * 1987-08-11 2006-09-07 New York University Biologisch-aktive Bakterizide/permeabilitätserhöhende Proteinbruchstücke
SE469132B (sv) * 1989-06-16 1993-05-17 Kabigen Ab Polypeptider och farmaceutisk komposition innehaallande denna

Also Published As

Publication number Publication date
SE468516B (sv) 1993-02-01
EP0589995B1 (en) 1999-03-24
EP0589995A1 (en) 1994-04-06
AU2022092A (en) 1993-01-12
JP3532917B2 (ja) 2004-05-31
ATE178072T1 (de) 1999-04-15
CA2111340C (en) 2002-08-20
GR3029887T3 (en) 1999-07-30
ES2131528T3 (es) 1999-08-01
SE9101838L (sv) 1992-12-15
WO1992022578A1 (en) 1992-12-23
CA2111340A1 (en) 1992-12-23
DK0589995T3 (da) 1999-07-19
DE69228749D1 (de) 1999-04-29
AU667472B2 (en) 1996-03-28
DE69228749T2 (de) 1999-07-22
US5489575A (en) 1996-02-06
JPH07502013A (ja) 1995-03-02

Similar Documents

Publication Publication Date Title
SE9101838D0 (sv) Novel peptides and their use
DK0728148T3 (da) Forbedrede immunogene sammensætninger mod humant gastrin 17
TW279166B (sv)
RU94046291A (ru) Способ профилактики и лечения периферической невропатии, композиция, содержащая инсулин-подобный фактор роста i
MX9705710A (es) Compuestos con propiedades de liberacion de la hormona del crecimiento.
EP0528858A4 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
IL112112A0 (en) Peptide derivatives and pharmaceutical compositions containing them
NO952321L (no) Polypeptid, samt anti-HIV-preparat fremstilt fra dette
DE69326776D1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
HUP9900935A2 (hu) Baktériumellenes és gombaellenes hatású peptid és eljárás az előállítására
AU3078892A (en) Human interleukin-8 analogs
ATE364079T1 (de) Peptide mit gdp-austauschfaktorartiger wirkung, dafür kodierende nukleinsäuresequenzen, ihre herstellung und verwendung
GB9219936D0 (en) Vaccines
DK0561846T3 (da) 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning
DK0403458T3 (da) Hidtil ukendte polypeptider og anvendelse deraf
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use
ATE121422T1 (de) Neue antikoagulatorisch wirksame peptide.
MX9205978A (es) Nuevas proteinas inhibidoras de trombina de garrapatas.
GB9604518D0 (en) Novel compounds
TW346397B (en) Cell cycle controlling compositions and methods of using same
KR920700224A (ko) 신규의 생리활성 펩티드 및 이를 유효성분으로서 함유한 칼슘대사 조절제

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 9101838-2

Format of ref document f/p: F

NUG Patent has lapsed